Natural History and Complications of IBD

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2009 Nov 12

PMID 19903424

Citations 31

Authors

Morten H Vatn

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel diseases (IBD), mainly ulcerative colitis and Crohn's disease, are chronic, heterogenic, lifelong illnesses with young age of onset and a great potential for disability. The natural history of these diseases is influenced by multiple factors of environmental and genetic origin. Multidisciplinary research has increased our knowledge of the mechanisms involved during the development and outcome of the diseases, including disease complications. Immunomodulatory treatment has demonstrated greatly improved efficacy in moderate to severe disease activity. The long-term effect on the natural course of disease and sustained reduced burden on society over many years require study. This article summarizes recent knowledge on factors influencing the natural history of IBD, including the impact of treatment. Increased understanding of disease mechanisms is needed as a basis for new treatment strategies in the future.

Citing Articles

Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review.

Ratajczak A, Festa S, Aratari A, Papi C, Dobrowolska A, Krela-Kazmierczak I Front Nutr. 2023; 9:1088693.

PMID: 36704787 PMC: 9871561. DOI: 10.3389/fnut.2022.1088693.

Outcomes of endoscopic retrograde cholangiopancreatography in patients with inflammatory bowel disease: a nationwide study.

Kalligeros M, Kroner P, Farraye F, Desalermos A Int J Colorectal Dis. 2023; 38(1):23.

PMID: 36692549 DOI: 10.1007/s00384-023-04308-w.

Beneficial Role of Fruits, Their Juices, and Freeze-Dried Powders on Inflammatory Bowel Disease and Related Dysbiosis.

Perri M, Romano C, Marrelli M, Zicarelli L, Toma C, Basta D Plants (Basel). 2022; 11(1).

PMID: 35009009 PMC: 8747592. DOI: 10.3390/plants11010004.

Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

DAlessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S Nat Rev Gastroenterol Hepatol. 2021; 19(3):169-184.

PMID: 34876680 DOI: 10.1038/s41575-021-00543-0.

Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.

Nunez F P, Krugliak Cleveland N, Quera R, Rubin D World J Gastroenterol. 2021; 27(20):2521-2530.

PMID: 34092973 PMC: 8160621. DOI: 10.3748/wjg.v27.i20.2521.

References

Mahid S, Minor K, Soto R, Hornung C, Galandiuk S . Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006; 81(11):1462-71. DOI: 10.4065/81.11.1462. View

Mahadevan U, Sandborn W, Li D, Hakimian S, Kane S, Corley D . Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007; 133(4):1106-12. DOI: 10.1053/j.gastro.2007.07.019. View

Masunaga Y, Ohno K, Ogawa R, Hashiguchi M, Echizen H, Ogata H . Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother. 2007; 41(1):21-8. DOI: 10.1345/aph.1H219. View

Hoie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T . Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007; 102(8):1692-701. DOI: 10.1111/j.1572-0241.2007.01265.x. View

Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N . Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006; 41(9):1037-43. DOI: 10.1080/00365520600554527. View

Bernstein C, Wajda A, Svenson L, MacKenzie A, Koehoorn M, Jackson M . The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006; 101(7):1559-68. DOI: 10.1111/j.1572-0241.2006.00603.x. View

Abreu M, Taylor K, Lin Y, Hang T, Gaiennie J, Landers C . Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002; 123(3):679-88. DOI: 10.1053/gast.2002.35393. View

Ley R, Peterson D, Gordon J . Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006; 124(4):837-48. DOI: 10.1016/j.cell.2006.02.017. View

Jose F, Garnett E, Vittinghoff E, Ferry G, Winter H, Baldassano R . Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008; 15(1):63-8. PMC: 2605161. DOI: 10.1002/ibd.20604. View

10.

Moum B, Ekbom A, Vatn M, Aadland E, Sauar J, Lygren I . Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol. 1997; 32(10):1005-12. DOI: 10.3109/00365529709011217. View

11.

Loly C, Belaiche J, Louis E . Predictors of severe Crohn's disease. Scand J Gastroenterol. 2008; 43(8):948-54. DOI: 10.1080/00365520801957149. View

12.

Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn M . The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol. 2008; 168(9):1065-72. DOI: 10.1093/aje/kwn218. View

13.

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View

14.

Strober W, Fuss I, Mannon P . The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117(3):514-21. PMC: 1804356. DOI: 10.1172/JCI30587. View

15.

Renna S, Camma C, Modesto I, Cabibbo G, Scimeca D, Civitavecchia G . Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology. 2008; 135(5):1500-9. DOI: 10.1053/j.gastro.2008.07.066. View

16.

Sonnenberg A . Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004. J Clin Gastroenterol. 2008; 43(4):297-300. DOI: 10.1097/MCG.0b013e31816244a0. View

17.

Jarnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C . Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005; 128(7):1805-11. DOI: 10.1053/j.gastro.2005.03.003. View

18.

Cosnes J, Carbonnel F, Beaugerie L, Blain A, Reijasse D, Gendre J . Effects of appendicectomy on the course of ulcerative colitis. Gut. 2002; 51(6):803-7. PMC: 1773481. DOI: 10.1136/gut.51.6.803. View

19.

Odes S, Vardi H, Friger M, Wolters F, Russel M, Riis L . Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology. 2006; 131(3):719-28. DOI: 10.1053/j.gastro.2006.05.052. View

20.

Bengtson M, Solberg C, Aamodt G, Jahnsen J, Moum B, Sauar J . Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease. Inflamm Bowel Dis. 2009; 15(12):1867-74. DOI: 10.1002/ibd.20978. View